Publication: A Phase III open-label, randomized, multicenter study of imprime pgg in combination with cetuximab in patients with kras wild type metastatic colorectal cancer
Loading...
Open/View Files
Date
2014
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Meyerhardt, Jeffrey A, Michele M Grady, Jamie N Lowe, Michele A Gargano, Richard D Huhn, and Ada H Braun. 2014. “A Phase III open-label, randomized, multicenter study of imprime pgg in combination with cetuximab in patients with kras wild type metastatic colorectal cancer.” Journal for Immunotherapy of Cancer 2 (Suppl 3): P71. doi:10.1186/2051-1426-2-S3-P71. http://dx.doi.org/10.1186/2051-1426-2-S3-P71.
Abstract
Description
Other Available Sources
Research Data
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service